{"id":"https://openalex.org/W4362545653","doi":"https://doi.org/10.1158/1535-7163.c.6539340","title":"Data from Co-targeting HGF/cMET Signaling with MEK Inhibitors in Metastatic Uveal Melanoma","display_name":"Data from Co-targeting HGF/cMET Signaling with MEK Inhibitors in Metastatic Uveal Melanoma","publication_year":2023,"publication_date":"2023-04-03","ids":{"openalex":"https://openalex.org/W4362545653","doi":"https://doi.org/10.1158/1535-7163.c.6539340"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.c.6539340","doi":"https://doi.org/10.1158/1535-7163.c.6539340","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1535-7163.c.6539340","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://dx.doi.org/10.1158/1535-7163.c.6539340","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5087595506","display_name":"Hanyin Cheng","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hanyin Cheng","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055634444","display_name":"Vivian Y.L. Chua","orcid":"https://orcid.org/0000-0002-1873-6820","observed_orcids":["https://orcid.org/0000-0002-1873-6820"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Vivian Chua","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060883368","display_name":"Connie Liao","orcid":"https://orcid.org/0009-0006-2846-9638","observed_orcids":["https://orcid.org/0009-0006-2846-9638"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Connie Liao","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085398803","display_name":"Timothy J. Purwin","orcid":"https://orcid.org/0000-0002-7053-8039","observed_orcids":["https://orcid.org/0000-0002-7053-8039"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Timothy J. Purwin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036217332","display_name":"Mizue Terai","orcid":"https://orcid.org/0000-0003-2672-9468","observed_orcids":["https://orcid.org/0000-0003-2672-9468"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mizue Terai","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030422981","display_name":"Ken Kageyama","orcid":"https://orcid.org/0000-0002-0787-9789","observed_orcids":["https://orcid.org/0000-0002-0787-9789"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ken Kageyama","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048327749","display_name":"Michael A. Davies","orcid":"https://orcid.org/0000-0002-0977-0912","observed_orcids":["https://orcid.org/0000-0002-0977-0912"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael A. Davies","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053828591","display_name":"Takami Sato","orcid":"https://orcid.org/0000-0003-2221-0415","observed_orcids":["https://orcid.org/0000-0003-2221-0415"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Takami Sato","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5062746446","display_name":"Andrew E. Aplin","orcid":"https://orcid.org/0000-0002-2734-3244","observed_orcids":["https://orcid.org/0000-0002-2734-3244"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andrew E. Aplin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11328","display_name":"Ocular Oncology and Treatments","score":0.9785000085830688,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11328","display_name":"Ocular Oncology and Treatments","score":0.9785000085830688,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.014299999922513962,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11194","display_name":"Ocular Diseases and Beh\u00e7et\u2019s Syndrome","score":0.00139999995008111,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/metastatic-uveal-melanoma","display_name":"metastatic uveal melanoma","score":0.9850000143051147},{"id":"https://openalex.org/keywords/mek-inhibitor-resistance","display_name":"MEK inhibitor resistance","score":0.9739999771118164},{"id":"https://openalex.org/keywords/trametinib","display_name":"trametinib","score":0.9559999704360962},{"id":"https://openalex.org/keywords/bmf","display_name":"BMF","score":0.984000027179718},{"id":"https://openalex.org/keywords/bh3-only-proteins","display_name":"BH3-only proteins","score":0.9860000014305115},{"id":"https://openalex.org/keywords/pi3k-isoforms","display_name":"PI3K isoforms","score":0.9649999737739563},{"id":"https://openalex.org/keywords/akt-phosphorylation","display_name":"Akt phosphorylation","score":0.8519999980926514},{"id":"https://openalex.org/keywords/hepatic-stellate-cells","display_name":"hepatic stellate cells","score":0.8529999852180481},{"id":"https://openalex.org/keywords/liver-metastases","display_name":"liver metastasis","score":0.8040000200271606},{"id":"https://openalex.org/keywords/ron-receptor","display_name":"RON receptor","score":0.625},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.546999990940094},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.8040000200271606}],"concepts":[{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.7870330810546875},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.726829469203949},{"id":"https://openalex.org/C2778472372","wikidata":"https://www.wikidata.org/wiki/Q7833138","display_name":"Trametinib","level":4,"score":0.6778966784477234},{"id":"https://openalex.org/C2776996007","wikidata":"https://www.wikidata.org/wiki/Q2399112","display_name":"Hepatocyte growth factor","level":3,"score":0.5985851287841797},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.5502481460571289},{"id":"https://openalex.org/C75217442","wikidata":"https://www.wikidata.org/wiki/Q423650","display_name":"Protein kinase B","level":3,"score":0.5466710329055786},{"id":"https://openalex.org/C2781249067","wikidata":"https://www.wikidata.org/wiki/Q17142288","display_name":"MEK inhibitor","level":4,"score":0.5223868489265442},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5051863789558411},{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.446292519569397},{"id":"https://openalex.org/C2779013556","wikidata":"https://www.wikidata.org/wiki/Q181876","display_name":"Metastasis","level":3,"score":0.44595175981521606},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.425201952457428},{"id":"https://openalex.org/C97029542","wikidata":"https://www.wikidata.org/wiki/Q281417","display_name":"Protein kinase A","level":3,"score":0.41483795642852783},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.38023900985717773},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3370477557182312},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2462666630744934},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2435128092765808},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.16835200786590576},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.0792723298072815}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/1535-7163.c.6539340","doi":"https://doi.org/10.1158/1535-7163.c.6539340","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1535-7163.c.6539340","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/1535-7163.c.6539340.v1","doi":"https://doi.org/10.1158/1535-7163.c.6539340.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.c.6539340.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1535-7163.c.6539340","doi":"https://doi.org/10.1158/1535-7163.c.6539340","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1535-7163.c.6539340","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2582283428","https://openalex.org/W2504266415","https://openalex.org/W4392687471","https://openalex.org/W2150915626","https://openalex.org/W7098267238","https://openalex.org/W2561067358","https://openalex.org/W3208917129","https://openalex.org/W835444613","https://openalex.org/W4317821416","https://openalex.org/W3134215187"],"abstract_inverted_index":{"Abstract":[0],"Patients":[1],"with":[2,51,98,149],"metastatic":[3,70,160,179],"uveal":[4,52,71,161,180],"melanoma":[5,43,162,181],"usually":[6],"die":[7],"within":[8],"1":[9],"year":[10],"of":[11,29,80,135,147],"diagnosis,":[12],"emphasizing":[13],"an":[14],"urgent":[15],"need":[16],"to":[17,66,89,92,115,141,187],"develop":[18],"new":[19],"treatment":[20],"strategies.":[21],"The":[22],"liver":[23],"is":[24],"the":[25,139,168,184,197],"most":[26],"common":[27],"site":[28],"metastasis.":[30],"Mitogen-activated":[31],"protein":[32],"kinase":[33,34],"(MEK)":[35],"inhibitors":[36,68,143,189],"improve":[37],"survival":[38],"in":[39,49,69,159,178,196],"V600":[40],"BRAF\u2013mutated":[41],"cutaneous":[42],"patients":[44,50],"but":[45],"have":[46],"limited":[47],"efficacy":[48],"melanoma.":[53,72],"Our":[54],"previous":[55],"work":[56],"showed":[57],"that":[58,78,133,170],"hepatocyte":[59],"growth":[60],"factor":[61],"(HGF)":[62],"signaling":[63,97,174],"elicits":[64],"resistance":[65,91,114,140,186],"MEK":[67,93,142,188],"In":[73],"this":[74],"study,":[75],"we":[76],"demonstrate":[77],"expression":[79],"two":[81],"BH3-only":[82],"family":[83],"proteins,":[84],"Bim-EL":[85],"and":[86,102,107,121,154],"Bmf,":[87],"contributes":[88],"HGF-mediated":[90],"inhibitors.":[94],"Targeting":[95],"HGF/cMET":[96],"LY2875358,":[99],"a":[100,109],"neutralizing":[101],"internalizing":[103],"anti-cMET":[104],"bivalent":[105],"antibody,":[106],"LY2801653,":[108],"dual":[110],"cMET/RON":[111],"inhibitor,":[112],"overcomes":[113],"trametinib":[116,150],"provided":[117,190],"by":[118,122,144,191],"exogenous":[119],"HGF":[120],"conditioned":[123],"medium":[124],"from":[125,193],"primary":[126],"hepatic":[127],"stellate":[128],"cells.":[129],"We":[130],"further":[131],"determined":[132],"activation":[134],"PI3K\u03b1/\u03b3/\u03b4":[136],"isoforms":[137,177],"mediates":[138],"HGF.":[145],"Combination":[146],"LY2801653":[148],"decreases":[151],"AKT":[152],"phosphorylation":[153],"promotes":[155],"proapoptotic":[156],"PARP":[157],"cleavage":[158],"explants.":[163],"Together,":[164],"our":[165],"data":[166],"support":[167],"notion":[169],"selectively":[171],"blocking":[172],"cMET":[173],"or":[175],"PI3K":[176],"may":[182],"break":[183],"intrinsic":[185],"factors":[192],"stromal":[194],"cells":[195],"liver.":[198],"Mol":[199],"Cancer":[200],"Ther;":[201],"16(3);":[202],"516\u201328.":[203],"\u00a92017":[204],"AACR.":[205]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-04-06T00:00:00"}